IGFBP7 and acute kidney injury: Monitoring urine biomarkers, such as tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP-7), for acute kidney injury in high-risk patients may help guide interventions [4].